RudaCure attended Bio韩国 2021, held at COEX in 首尔, and used the opportunity to showcase its 干眼症治疗药 candidate RCI001 and 疼痛治疗药 管线 RCI002 to major 国内外 制药公司 and investors.
Through various networking sessions at the conference, the company engaged in active discussions on future research collaboration and technology licensing opportunities.